Glioblastoma Foundation Opens Genomic Testing & Research Laboratory

The Glioblastoma Foundation is set to unveil its Genomic Testing & Research Laboratory on September 3, 2024. This state-of-the-art facility in Durham, NC, aims to revolutionize glioblastoma treatment by providing advanced genomic testing and personalized drug identification. This initiative promises to shift glioblastoma diagnosis from terminal to treatable.

The event will feature tours of the lab, allowing attendees to meet the team behind this groundbreaking project. Key figures, like Gita Kwatra, CEO of the Glioblastoma Foundation, and experts from Johns Hopkins University and Atrium Health Wake Forest Baptist, will be present to share insights. The ceremony will culminate with a ribbon-cutting at noon.

The lab will offer vital, low-cost testing services with faster turnaround times to improve patient outcomes and quality of life. The ceremony will take place at The Chesterfield Building in Durham, NC, and will include informational speeches and guided tours, followed by a catered lunch.